Anti-HMGB1 Rabbit Monoclonal Antibody: Practical Workflow Guide

HMGB1 is a non-histone chromatin protein involved in DNA architecture modulation, including DNA bending and helix unwinding. Detecting it in lysates, tissue sections, or cells can help researchers examine HMGB1 abundance and distribution in a defined experimental model. The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) is an affinity-purified, unconjugated rabbit monoclonal antibody listed for Western blot (WB), frozen and paraffin-embedded tissue immunohistochemistry (IHC-F and IHC-P), and flow cytometry (FC).

This guide separates product-dossier specifications from general workflow recommendations. No directly matched paper evidence is available for this product, so the guidance below does not claim publication-specific validation, a guaranteed dilution, or performance in a particular model.

What This Product Solves

MA3057 offers one HMGB1 antibody for several commonly used detection formats and is listed as reactive with human, mouse, and rat HMGB1. That species coverage can be useful when comparing samples across these organisms, but it does not replace checking the species and sample type in each experiment. The product is an IgG isotype and is supplied as a liquid, unconjugated reagent; flow cytometry and other detection workflows therefore require a compatible secondary antibody unless the assay design specifies another detection approach.

For Western blot HMGB1 detection, the dossier gives an approximate calculated molecular weight of 25 kDa and an observed molecular weight of 29 kDa. These values are a reference for band assessment, not proof that any band at that position is HMGB1. Immunohistochemistry HMGB1 workflows can be planned for either frozen or paraffin-embedded tissue, while flow cytometry HMGB1 antibody use should be treated as an assay to optimize with appropriate cell preparation and controls.

The protein’s reported role in chromatin and transcriptional interactions provides biological context, not a functional readout for this antibody. Use the reagent to detect HMGB1 protein; do not infer DNA architecture modulation, transcriptional activity, or other function from staining intensity alone.

Protocol Parameters

Protocol Parameters

• Assay: Western blot. Parameter: HMGB1 is approximately 25 kDa calculated and 29 kDa observed. Applicability: Use as a reference when assessing lysate bands. Rationale: Apparent migration can differ from calculated mass, so evaluate the band alongside controls and the full blot. Basis: Product-dossier specification.
• Assay: IHC-F and IHC-P. Parameter: Listed reactivity covers human, mouse, and rat HMGB1; no retrieval condition or working dilution is specified in the dossier. Applicability: Frozen and paraffin-embedded tissue sections. Rationale: Fixation and processing affect epitope accessibility and background. Basis: Species and application are product specifications; retrieval and titration are workflow recommendations.
• Assay: Flow cytometry. Parameter: Unconjugated IgG; the antibody concentration is specified on the product label, while a working dilution is not stated here. Applicability: Select a compatible secondary and a cell preparation appropriate for intracellular HMGB1 detection. Rationale: The antibody itself is not fluorophore-conjugated, and HMGB1 is a chromatin protein. Basis: Product specification and workflow recommendation.
• Assay: Reagent handling across workflows. Parameter: Store at -20°C; stated shelf life is 12 months under recommended storage conditions. Formulation includes 50 mM Tris-Glycine, pH 7.4, 0.15 M NaCl, 40% glycerol, 0.01% sodium azide, and 0.05% BSA. Applicability: Storage, aliquoting, and compatibility checks. Rationale: Follow the supplied formulation and avoid repeated freeze-thaw cycles. Basis: Product-dossier specification.

Workflow Setup and QC Checklist

1. Confirm the experiment and sample. Choose WB, IHC-F, IHC-P, or FC based on the readout required. Check that the sample species is human, mouse, or rat and that the material is appropriate for the selected assay.
2. Review the vial label before pipetting. Use the lot-specific concentration and handling information. The dossier does not provide a universal working dilution; begin with a small titration rather than assuming a concentration that worked for another antibody or assay.
3. Prepare assay-appropriate controls. For WB, include a sample expected to contain HMGB1 and a suitable negative or comparison sample when available. For IHC and FC, include secondary-only or other assay-appropriate background controls. Where practical, compare with an orthogonal HMGB1 detection method or a sample with independently established HMGB1 status.
4. For WB, prepare lysates consistently, load comparable total protein, and retain enough gel and membrane information to inspect background and band shape. Assess signal near the dossier’s approximate observed mass, but do not identify a band by size alone. Include molecular-weight markers and a loading or transfer control.
5. For IHC, keep fixation and tissue processing consistent across comparison groups. Optimize antigen retrieval for paraffin sections and fixation conditions for frozen sections; the product dossier does not prescribe either. Include controls that help separate primary-antibody signal from endogenous staining and secondary-reagent background.
6. For FC, plan an intracellular staining workflow with fixation and permeabilization suited to the sample and the intended readout. Titrate the primary and compatible secondary, and use unstained and single-stained controls as appropriate for the instrument and panel. Because the formulation contains sodium azide, do not assume the antibody is suitable for live-cell staining; check reagent compatibility and the assay design.
7. Document the result. Record antibody lot, label concentration, dilution tested, sample preparation, incubation conditions, detection reagents, and control outcomes. This makes optimization reproducible without presenting an unverified setting as a product-specific protocol.

For a broader overview of the same reagent and its assay applications, see the Anti-HMGB1 Rabbit Monoclonal Antibody Guide; it likewise distinguishes dossier details from workflow optimization in the absence of directly matched paper evidence.

Common Failure Modes and Fixes

• Weak or absent signal: Confirm the sample species, sample preparation, transfer or tissue processing, and detection-reagent compatibility. Titrate the primary using the label concentration as the starting reference and check that the secondary recognizes rabbit IgG.
• Unexpected bands in WB: Do not rely on molecular weight alone. Compare positive and negative samples, inspect the full blot, and adjust primary or secondary concentration if background is high. Confirm sample integrity and use an orthogonal check before assigning band identity.
• High IHC background: Review fixation, retrieval, blocking, and wash steps. Test conditions on a control section before interpreting experimental differences. The dossier does not specify retrieval chemistry or an IHC dilution, so these require local optimization.
• Diffuse or inconsistent FC staining: Check fixation and permeabilization, cell viability before processing, compensation and secondary-only controls, and the chosen gating strategy. As an unconjugated antibody, MA3057 requires a compatible detection scheme; it is not a directly labeled reagent.
• Declining performance after storage: Follow the -20°C storage recommendation and minimize freeze-thaw cycles. Inspect the vial and follow local handling procedures; do not infer that an altered appearance or repeated warming is harmless.

Scope and Limitations

The dossier supports detection of HMGB1 from human, mouse, and rat samples in the listed WB, IHC-F, IHC-P, and FC applications. It does not provide an assay-specific dilution, incubation schedule, antigen-retrieval recipe, flow-cytometry panel, or lot-level validation data in this guide. Conditions should therefore be established for the laboratory’s sample type and detection system. No directly matched paper evidence is available here; no paper-specific outcomes or independent performance claims should be inferred.

MA3057 is for scientific research use only and is not for diagnostic or medical purposes. The product information does not establish suitability for clinical testing, therapeutic use, or functional perturbation experiments. APExBIO lists the reagent for research applications; consult the product page and lot label for current product details.

For a related technical overview focused on assay setup and QC, see the Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Workflow Guide. It is supplementary workflow guidance, not evidence of paper-specific validation.

Conclusion

MA3057 is a rabbit monoclonal HMGB1 antibody listed for Western blot, frozen and paraffin-embedded tissue immunohistochemistry, and flow cytometry in human, mouse, and rat samples. Use the dossier’s molecular-weight and storage information as product references, then optimize dilution, sample preparation, and detection conditions with appropriate controls. Treat results as research data and avoid extending them beyond the assay and sample conditions actually tested.